Literature DB >> 21211578

Cost burden of second fracture in the US health system.

Xue Song1, Nianwen Shi, Enkhe Badamgarav, Joel Kallich, Helen Varker, Gregory Lenhart, Jeffrey R Curtis, Jeffery R Curtis.   

Abstract

OBJECTIVES: This retrospective claim-based study assessed 1-year medical costs associated with second fracture(s) for patients over 50 years old with an initial closed hip, clinical vertebral or non-hip non-vertebral (NHNV) fracture using 2002-2008 MarketScan® Commercial and Medicare Supplemental Databases.
METHODS: Patients with incident fracture and ≥12-month pre-period and follow-up period from the incident fracture were extracted. Index date was the first subsequent fracture date for patients with subsequent fracture during the 12-month (cases); index dates for patients without subsequent fractures during the 12-month follow-up (controls) were randomly assigned based on the distribution of index dates of cases. Total costs were examined during the 12-month follow-up period using generalized linear models. A decomposition analysis of the incremental costs attributable to the second fracture was conducted to examine what proportion of the difference was due to different patient characteristics and what proportion was due to different model structures between cases and controls.
RESULTS: For privately insured patients with hip, vertebral, or NHNV fracture, the 1-year second fracture rate was 8.0%, 5.1%, and 4.0%, and 1-year incremental costs were $47,351, $43,238, and $23,852, respectively; for Medicare patients, the corresponding rates and costs were 8.8%, 9.2%, and 8.2%, and $18,645, $19,702, and $19,697. Nationally projected annual cost of second fracture was $834 (95% confidence interval: $763-$914) million for patients with commercial insurance and $1.13 (95% confidence interval: $1.09-$1.17) billion for Medicare patients.
CONCLUSIONS: The average cost of patients with subsequent fracture(s) was substantial. Effective management of first fractures may help reduce the long-term economic and clinical burden.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21211578     DOI: 10.1016/j.bone.2010.12.021

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  Pain and fracture-related limitations persist 6 months after a fragility fracture.

Authors:  Joanna E M Sale; Lucy Frankel; Stephen Thielke; Larry Funnell
Journal:  Rheumatol Int       Date:  2017-06-20       Impact factor: 2.631

Review 2.  Osteoporotic fractures: a systematic review of U.S. healthcare costs and resource utilization.

Authors:  Sangeeta Budhia; Yeshi Mikyas; Michael Tang; Enkhe Badamgarav
Journal:  Pharmacoeconomics       Date:  2012-02-01       Impact factor: 4.981

3.  [Co-management in geriatric traumatology].

Authors:  C Kammerlander; M Blauth; M Gosch; W Böcker
Journal:  Orthopade       Date:  2015-09       Impact factor: 1.087

4.  The first reported fracture liaison service (FLS) for vertebral fractures in China: is muscle the missing gap?

Authors:  Ronald Man Yeung Wong; Shaau Yiu Ko; Wai-Wang Chau; Linus Chee Yeen Lee; Simon Kwoon Ho Chow; Wing Hoi Cheung; Sheung Wai Law
Journal:  Arch Osteoporos       Date:  2021-11-06       Impact factor: 2.617

5.  Promoting mobility after hip fracture (ProMo): study protocol and selected baseline results of a year-long randomized controlled trial among community-dwelling older people.

Authors:  Sarianna Sipilä; Anu Salpakoski; Johanna Edgren; Ari Heinonen; Markku A Kauppinen; Marja Arkela-Kautiainen; Sanna E Sihvonen; Maija Pesola; Taina Rantanen; Mauri Kallinen
Journal:  BMC Musculoskelet Disord       Date:  2011-12-07       Impact factor: 2.362

6.  Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.

Authors:  M M Bonafede; N Shi; A G Bower; R L Barron; A Grauer; D B Chandler
Journal:  Osteoporos Int       Date:  2015-01-08       Impact factor: 4.507

7.  Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures.

Authors:  Xue Song; Ruben G W Quek; Shravanthi R Gandra; Katherine A Cappell; Robert Fowler; Ze Cong
Journal:  BMC Health Serv Res       Date:  2015-06-25       Impact factor: 2.655

8.  Real-world bone turnover marker use: impact on treatment decisions and fracture.

Authors:  N E Lane; K Saag; T J O'Neill; M Manion; R Shah; U Klause; R Eastell
Journal:  Osteoporos Int       Date:  2020-11-24       Impact factor: 4.507

9.  Walking recovery after a hip fracture: a prospective follow-up study among community-dwelling over 60-year old men and women.

Authors:  Anu Salpakoski; Timo Törmäkangas; Johanna Edgren; Sanna Sihvonen; Mika Pekkonen; Ari Heinonen; Maija Pesola; Mauri Kallinen; Taina Rantanen; Sarianna Sipilä
Journal:  Biomed Res Int       Date:  2014-01-06       Impact factor: 3.411

10.  Economic Burden of Osteoporosis-Related Fractures in the US Medicare Population.

Authors:  Setareh A Williams; Shanette G Daigle; Richard Weiss; Yamei Wang; Tarun Arora; Jeffrey R Curtis
Journal:  Ann Pharmacother       Date:  2020-11-04       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.